@AASLDtweets Another great #liverMtg17 in the books. See you all in San Francisco next year!

@AASLDtweets upshot of dr. Kwo’s talk: #HCV drugs today cure almost all patients with almost no side effects in 8-16 weeks #LiverMtg17

@AASLDtweets 96% #HCV GT1b pts achieve SVR12 with 8 wks of #zepatier #LiverMtg17

@AASLDtweets Dr. Hirschfield: seladelpar reduces alkphos <1.67 ULN in 82% at 12 wks. No increased itching #LiverMtg17

@AASLDtweets anywhere between 3-9% #HCC pts on #nivolumab had significant ALT elevation but no signal for liver failure #LiverMtg17

@AASLDtweets #nivolumab 18-mo Overall survival 57% in #sorafenib-naive pts and 46% in sorafenib-experienced #HCC pts. #LiverMtg17

@AASLDtweets while it is fine to be passionate about organ equity, #LiverMtg17 podium must be governed by fair balance and evidence

@AASLDtweets reflecting on today’s Starzl lecture which may be the most controversial in history of the liver meeting #LiverMtg17

@AASLDtweets Unclear what solution to organ equity is. Currently, organ sharing at MELD 32 & 150 mile circles on the table #liverMtg17

@AASLDtweets Dr. Lake advocates a controversial 8 district solution to the organ disparity problem and refutes “ fake news” #LiverMtg17

@AASLDtweets Dr. John Lake talks proximity circles and redistricting as part of his organ equity Starzl lecture #LiverMtg17

@AASLDtweets I would invest more time and effort in expanding the 300 mil #HCV- vs. 2 mil HCV+ donor pool #LiverMtg17

@AASLDtweets use of #HCV DAAs has reduced 1-year mortality after transplant by 34%. Not entirely clear why #LiverMtg17

@AASLDtweets mathematical model suggests MELD cutoff where it is beneficial to accept #HCV+ liver for HCV- recipient is 20 #LiverMtg17

@AASLDtweets skinny from transplant plenary: everybody wants to put #HCV+ livers in HCV- pts. How and who is the question #LiverMtg17

@AASLDtweets can cirrhotics lose weight before transplant using endoscopic balloons? Maybe but not yet says Dr. Edmundowicz #livermtg17

@AASLDtweets Dr shergill: transplant recipients clearly at higher risk for colon cancer. Do colonoscopy within 3 years #livermtg17

@AASLDtweets Dr shergill: at the SF VA, a child c cirrhotic gets screened with CT colonography. Controversial. #livermtg17

@AASLDtweets Dr. Shergill: severe ascites lowers cecal intubation rate to about 77%. Should we tap beforehand? #LiverMtg17

@AASLDtweets Dr. Shergill: bowel preparation poor in 50% cirrhotics. Education before procedure may help.#livermtg17

@AASLDtweets Dr. Vargas: when resuscitating we often overshoot. Hb of 7 and Platelets <30k reasonable cutoffs to transfuse #LiverMtg17

@AASLDtweets Dr. Vargas: PT/INR helpful to assess liver function but does NOT predict bleeding risk #livermtg17

@AASLDtweets Dr Vargas: our tests to assess for coagulation status are flawed so tread carefully. Many are hypercoagualable #LiverMtg17

@AASLDtweets Dr. Vargas: when sedating cirrhotics for endoscopy, fentanyl seems to be safe and well tolerated #livermtg17

@AASLDtweets recurrent theme from dr. Vargas: when managing acute bleeding in cirrhotics, most docs don’t follow guidelines #livermtg17

@AASLDtweets Dr. Wani. Cirrhotics may benefit from endoscopic therapies for Barrett’s. EUS routine to detect varices. #livermtg17

@AASLDtweets Dr. Wani talking Barrett’s esophagus to hepatologists. “Most docs don’t follow surveillance guidelines” #livermtg17

One highlight of day 1 of #livermtg17 will be the @AASLDtweets @ASGEendoscopy course which will discuss challenges in cirrhotics

Don’t like to spend money or Uber? Smartrip it to your hotel or #livermtg17 from DCA in 20 mn

Looking forward to connecting with colleagues and learning the latest and greatest at #LiverMtg17 in DC @AASLDtweets